Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

3D bioprinting holds promise for medicine but needs more research and clear regulations.

Proper nutrition can help balance the immune system and reduce allergies.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Cooling with antioxidants helps protect hair during chemotherapy.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

Scalp cooling and minoxidil can help manage hair loss in children with cancer, but more research is needed.

Burn injuries can cause long-term itching, skin color changes, and cancer risks, needing personalized treatment.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

A young girl had a rare neck cyst removed and needs careful monitoring for related health issues.

More effective methods are needed to prevent hair loss from chemotherapy.

Skin cancer in sun-exposed areas is more likely to come back.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Sorafenib after liver surgery may increase survival for some liver cancer patients.